These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8522465)

  • 1. In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli.
    Luna-Herrera J; Reddy MV; Gangadharam PR
    J Antimicrob Chemother; 1995 Aug; 36(2):355-63. PubMed ID: 8522465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan.
    Chien HP; Yu MC; Ong TF; Lin TP; Luh KT
    J Formos Med Assoc; 2000 May; 99(5):408-11. PubMed ID: 10870331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
    Rastogi N; Goh KS; Berchel M; Bryskier A
    J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of cross-resistance between rifampin and rifabutin in Mycobacterium tuberculosis complex strains.
    Uzun M; Erturan Z; Anğ O
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):164-5. PubMed ID: 11931417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
    Senol G; Erbaycu A; Ozsöz A
    J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
    J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
    Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
    J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.
    García AB; Palacios JJ; Ruiz MJ; Barluenga J; Aznar F; Cabal MP; García JM; Díaz N
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5363-5. PubMed ID: 20855731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Yamada H; Mitarai S
    Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifabutin: where do we stand in 2016?
    Crabol Y; Catherinot E; Veziris N; Jullien V; Lortholary O
    J Antimicrob Chemother; 2016 Jul; 71(7):1759-71. PubMed ID: 27009031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.
    van Ingen J; Aarnoutse R; de Vries G; Boeree MJ; van Soolingen D
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):990-2. PubMed ID: 21682979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay.
    Yoshida S; Suzuki K; Iwamoto T; Tsuyuguchi K; Tomita M; Okada M; Sakatani M
    J Infect Chemother; 2010 Oct; 16(5):360-3. PubMed ID: 20354890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis.
    Fietta A; Morosini M; Cascina A
    J Chemother; 2001 Apr; 13(2):167-75. PubMed ID: 11330364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
    Dickinson JM; Mitchison DA
    Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.
    Luna-Herrera J; Reddy MV; Gangadharam PR
    Antimicrob Agents Chemother; 1995 Feb; 39(2):440-4. PubMed ID: 7726512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.